Log In
BCIQ
Print this Print this
 

Verigene Warfarin Metabolism Nucleic Acid Test

  Manage Alerts
Collapse Summary General Information
Company Luminex Corp.
DescriptionGenetic lab test that detects some variants of the CYP2C9 and VKORC1 genes
Molecular Target DNA
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsDetect some variants of the CYP2C9 and VKORC1 genes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$58.0M

$58.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/30/2016

$58.0M

$58.0M

0

Get a free BioCentury trial today